SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study.

ABSTRACT:

Aim

In a consecutive series of cancer patients tested for SARS-CoV-2 infection, this retrospective population-based study investigates the risks of viral infection and death.

Methods

Malignancies were distinguished as incident or prevalent (active or inactive). Cancer management and vital status were retrieved from institutional regional databases. Comorbidities were recorded, based on Adjusted Clinical Groups (ACG). Six Resource Utilization Bands (RUBs) were also considered. Independent risk factors for SARS-CoV-2 infection and death were identified using multivariable logistic regression, considering sex, age, comorbidities and RUBs, cancer status (active versus prevalent), primary cancer site, and treatments (chemotherapy and/or radiotherapy).

Results

Among

SUBMITTER: Zorzi M 

PROVIDER: S-EPMC8542867 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature